Max Chat
Calendrier des promotions Profound Medical Corp.
Calendrier avancé
Graphique simple
À propos de l'entreprise Profound Medical Corp.
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, palliative pain treatment of bone metastases, and osteoid osteoma. Profound Medical Corp. is headquartered in Mississauga, Canada.Paramètres de base
IPO date
2016-06-09
ISIN
CA74319B5027
Industry
Health Care Equipment & Supplies
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 17.41 | 1 |
| P/BV | 3.08 | 5 |
| P/E | 0 | 0 |
Efficacité
| Nom | Signification | Grade |
| ROA | -46.4 | 0 |
| ROE | -57.84 | 0 |
| ROIC | 0 | 0 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 0 | 0 |
| DSI | 0 | 0 |
| Croissance moyenne du dividende | 0 | 0 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | -0.1549 | 10 |
| Debt/Ratio | 0.0729 | 10 |
| Debt/Equity | 0.1624 | 10 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | 46.3 | 6 |
| Rentabilité Ebitda, % | 99.17 | 9 |
| Rentabilité EPS, % | -14.46 | 0 |
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 6.54 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.7d | 6.75 $ | 0 $ | 0 $ | -3.11 % | 0 % | 0 % |
| common.calendar.number_days.30d | 5.13 $ | 5.57 $ | 6.79 $ | 27.49 % | 0 % | 0 % |
| common.calendar.number_days.90d | 4.69 $ | 4.04 $ | 6.79 $ | 39.45 % | 0 % | 0 % |
| common.calendar.number_days.180d | 6.14 $ | 4.04 $ | 7.68 $ | 6.51 % | 0 % | 0 % |
| common.calendar.number_days.1y | 9.02 $ | 4.04 $ | 11.18 $ | -27.49 % | 0 % | 0 % |
| common.calendar.number_days.3y | 7.25 $ | 3.18 $ | 14.88 $ | -9.79 % | 0 % | 0 % |
| common.calendar.number_days.5y | 15.66 $ | 3.18 $ | 28.09 $ | -58.24 % | 0 % | 0 % |
| common.calendar.number_days.10y | 0.003 $ | 0.003 $ | 28.09 $ | 218000 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 6.45 $ | 4.04 $ | 7.9 $ | 1.4 % | 0 % | 0 % |
Principaux propriétaires
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Dr. Arun Swarup Menawat MBA, Ph.D. | Chairman of the Board & CEO | 435.87k | 1955 (70 années) |
| Mr. Rashed Dewan | Chief Financial Officer | 215.18k | 1968 (57 années) |
| Mr. Hartmut Warnken | Senior Vice President for Strategic Alliances | 226.17k | 1973 (52 année) |
| Dr. Mathieu Burtnyk | Chief Operating Officer | 215.18k | 1982 (43 année) |
| Mr. Stephen Kilmer | Investor Relations | N/A | |
| Mr. Jacques F. Cornet | VP of International Sales & Marketing | N/A | 1956 (69 années) |
| Mr. Matthew Sobczyk C.A., CPA | Assistant Corporate Controller | N/A | |
| Mr. Levant Tinaz | Software Developer | N/A | |
| Ms. Abbey Goodman | Chief Commercial Officer of Global | 1983 (42 année) |
Informations sur l'entreprise
Adresse: Canada, Mississauga. ON LW K, 2400 Skymark Avenue - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.profoundmedical.com
Site web: https://www.profoundmedical.com
